Surgical or transcatheter aortic-valve replacement in intermediate-risk patients

New England Journal of Medicine

Volumn 376, Issue 14, 2017, Pages 1321-1331

  Reardon, M J ^a   Van Mieghem, N M ^b   Popma, J J ^c   Kleiman, N S ^a   Sondergaard, L ^d   Mumtaz, M ^e   Adams, D H ^g   Deeb, G M ^h   Maini, B ^k   Gada, H ^e   Chetcuti, S ⁱ   Gleason, T ^f   Heiser, J ^j   Lange, R ^l   Merhi, W ^j   Oh, J K ⁿ   Olsen, P S ^d   Piazza, N ^q   Williams, M ^g   Windecker, S ^r   Yakubov, S J ^s   Grube, E ^m   Makkar, R ^t   Lee, J S ^f   Conte, J ^u   Vang, E ^o   Nguyen, H ^o   Chang, Y ^o   Mugglin, A S ^p   Serruys, P W J C ^b   Kappetein, A P ^b   more..

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Bcth Israel Deaconess Medical Center   (United States)

^d Rigshospitalet   (Denmark)

^e Pinnacle Health System   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g MOUNT SINAI HEALTH SYSTEM   (United States)

^h NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j SPECTRUM HEALTH   (United States)

^k Tenet Healthcare   (United States)

^l TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^m Heart Center Siegburg   (Germany)

ⁿ MAYO CLINIC   (United States)

^o Medtronic   (United States)

^p Paradigm Biostatistics LLC   (United States)

^q MCGILL UNIVERSITY   (Canada)

^r UNIVERSITY OF BERN   (Switzerland)

^s RIVERSIDE METHODIST HOSPITAL   (United States)

^t CEDARS SINAI MEDICAL CENTER   (United States)

^u JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; ATRIAL FIBRILLATION; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HUMAN; INTERMEDIATE RISK PATIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PATIENT SAFETY; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SELF EXPANDING AORTA VALVE PROSTHESIS; SURGICAL RISK; THROMBOSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; BAYES THEOREM; CLINICAL TRIAL; COMPARATIVE STUDY; HEART VALVE REPLACEMENT; MORTALITY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BAYES THEOREM; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85017306295     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1700456     Document Type: Article

References (20)

1. Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014; 63: 1972-81.
2. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370: 1790-8.
3. Reardon MJ, Adams DH, Kleiman NS, et al. 2-Year outcomes in patients under- going surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 2015; 66: 113-21.
4. Deeb GM, Reardon MJ, Chetcuti S, et al. 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 67: 2565-74.
5. Holmes DR Jr, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. Ann Thorac Surg 2016; 101: 789-800.
6. Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate- risk surgical patients. JACC Cardiovasc Interv 2013; 6: 443-51.
7. Iturra SA, Suri RM, Greason KL, et al. Outcomes of surgical aortic valve replacement in moderate risk patients: implications for determination of equipoise in the transcatheter era. J Thorac Cardiovasc Surg 2014; 147: 127-32.
8. Tamburino C, Barbanti M, D'Errigo P, et al. 1-Year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study. J Am Coll Cardiol 2015; 66: 804-12.
9. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016; 374: 1609-20.
10. Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013; 145: 6-23.
11. Arnold SV, Reynolds MR, Wang K, et al. Health status after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis at increased surgical risk: Results from the CoreValve US Pivotal Trial. JACC Cardiovasc Interv 2015; 8: 1207-17.
12. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607.
13. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-98.
14. Siontis GC, Praz F, Pilgrim T, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: A metaanalysis of randomized trials. Eur Heart J 2016; 37: 3503-12.
15. Guadiani V, Deeb GM, Popma JJ, et al. Causes of death in the randomized CoreValve US Pivotal High-Risk Trial. J Thorac Cardiovasc Surg 2017 February 4 (Epub ahead of print).
16. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery. Ann Thorac Surg 2009; 88: Suppl: S23-S42.
17. Green P, Woglom AE, Genereux P, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: A single-center experience. JACC Cardiovasc Interv 2012; 5: 974-81.
18. Hermiller JB Jr, Yakubov SJ, Reardon MJ, et al. Predicting early and late mortality after transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 68: 343-52.
19. Popma JJ, Reardon MJ, Khabbaz K, et al. Early clinical outcomes after transcatheter aortic valve replacement using a novel selfexpanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery: Results of the Evolut R U.S. Study. JACC Cardiovasc Interv 2017; 10: 268-75.
20. Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-Annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv 2015; 8: 1359-67.